Adam Castaño

Adam Castaño works in Heart Failure / Cardiomyopathy affiliated with BridgeBio (United States).

Adam Castaño, MD, MS is Chief Medical Officer at BridgeBio Cardiovascular and Vice President of Global Clinical Development at BridgeBio Pharma, with a focus on ATTR amyloidosis. He previously held clinical and research roles at institutions including Boston University, Brigham and Women's Hospital, Boston Medical Center, Mayo Clinic, and University Medical Center Groningen.